The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Musculoskeletal System Disorder Market Research Report 2024
Synopsis
Musculoskeletal system disorders are the second-highest contributor to global disability and an estimated 20%–33% of people across the globe live with a painful musculoskeletal condition.
The global Musculoskeletal System Disorder market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Musculoskeletal System Disorder is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Musculoskeletal System Disorder is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Musculoskeletal System Disorder in Hospitals & Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Musculoskeletal System Disorder include AB Science, AbGenomics International, Inc., Alder BioPharmaceuticals,Inc., Amgen Inc., Lexicon Pharmaceuticals, Inc., LG Chem, OrthoTrophix, Inc., Tarsa Therapeutics, Inc. and PhytoHealth Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Musculoskeletal System Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Musculoskeletal System Disorder.
Report Scope
The Musculoskeletal System Disorder market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Musculoskeletal System Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Musculoskeletal System Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB Science
AbGenomics International, Inc.
Alder BioPharmaceuticals,Inc.
Amgen Inc.
Lexicon Pharmaceuticals, Inc.
LG Chem
OrthoTrophix, Inc.
Tarsa Therapeutics, Inc.
PhytoHealth Corporation
Eisai Co., Ltd
Astellas Pharma Inc.
AstraZeneca
Baxter
GlaxoSmithKline PLC
Segment by Type
Rheumatoid Arthritis
Osteoarthritis
Osteoporosis
Others
Segment by Application
Hospitals & Clinics
Academic & Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Musculoskeletal System Disorder companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Musculoskeletal system disorders are the second-highest contributor to global disability and an estimated 20%–33% of people across the globe live with a painful musculoskeletal condition.
The global Musculoskeletal System Disorder market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Musculoskeletal System Disorder is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Musculoskeletal System Disorder is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Musculoskeletal System Disorder in Hospitals & Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Musculoskeletal System Disorder include AB Science, AbGenomics International, Inc., Alder BioPharmaceuticals,Inc., Amgen Inc., Lexicon Pharmaceuticals, Inc., LG Chem, OrthoTrophix, Inc., Tarsa Therapeutics, Inc. and PhytoHealth Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Musculoskeletal System Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Musculoskeletal System Disorder.
Report Scope
The Musculoskeletal System Disorder market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Musculoskeletal System Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Musculoskeletal System Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB Science
AbGenomics International, Inc.
Alder BioPharmaceuticals,Inc.
Amgen Inc.
Lexicon Pharmaceuticals, Inc.
LG Chem
OrthoTrophix, Inc.
Tarsa Therapeutics, Inc.
PhytoHealth Corporation
Eisai Co., Ltd
Astellas Pharma Inc.
AstraZeneca
Baxter
GlaxoSmithKline PLC
Segment by Type
Rheumatoid Arthritis
Osteoarthritis
Osteoporosis
Others
Segment by Application
Hospitals & Clinics
Academic & Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Musculoskeletal System Disorder companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Musculoskeletal System Disorder Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rheumatoid Arthritis
1.2.3 Osteoarthritis
1.2.4 Osteoporosis
1.2.5 Others
1.3 Market by Application
1.3.1 Global Musculoskeletal System Disorder Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinics
1.3.3 Academic & Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Musculoskeletal System Disorder Market Perspective (2019-2030)
2.2 Musculoskeletal System Disorder Growth Trends by Region
2.2.1 Global Musculoskeletal System Disorder Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Musculoskeletal System Disorder Historic Market Size by Region (2019-2024)
2.2.3 Musculoskeletal System Disorder Forecasted Market Size by Region (2025-2030)
2.3 Musculoskeletal System Disorder Market Dynamics
2.3.1 Musculoskeletal System Disorder Industry Trends
2.3.2 Musculoskeletal System Disorder Market Drivers
2.3.3 Musculoskeletal System Disorder Market Challenges
2.3.4 Musculoskeletal System Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Musculoskeletal System Disorder Players by Revenue
3.1.1 Global Top Musculoskeletal System Disorder Players by Revenue (2019-2024)
3.1.2 Global Musculoskeletal System Disorder Revenue Market Share by Players (2019-2024)
3.2 Global Musculoskeletal System Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Musculoskeletal System Disorder Revenue
3.4 Global Musculoskeletal System Disorder Market Concentration Ratio
3.4.1 Global Musculoskeletal System Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal System Disorder Revenue in 2023
3.5 Musculoskeletal System Disorder Key Players Head office and Area Served
3.6 Key Players Musculoskeletal System Disorder Product Solution and Service
3.7 Date of Enter into Musculoskeletal System Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Musculoskeletal System Disorder Breakdown Data by Type
4.1 Global Musculoskeletal System Disorder Historic Market Size by Type (2019-2024)
4.2 Global Musculoskeletal System Disorder Forecasted Market Size by Type (2025-2030)
5 Musculoskeletal System Disorder Breakdown Data by Application
5.1 Global Musculoskeletal System Disorder Historic Market Size by Application (2019-2024)
5.2 Global Musculoskeletal System Disorder Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Musculoskeletal System Disorder Market Size (2019-2030)
6.2 North America Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Musculoskeletal System Disorder Market Size by Country (2019-2024)
6.4 North America Musculoskeletal System Disorder Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Musculoskeletal System Disorder Market Size (2019-2030)
7.2 Europe Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Musculoskeletal System Disorder Market Size by Country (2019-2024)
7.4 Europe Musculoskeletal System Disorder Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Musculoskeletal System Disorder Market Size (2019-2030)
8.2 Asia-Pacific Musculoskeletal System Disorder Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2019-2024)
8.4 Asia-Pacific Musculoskeletal System Disorder Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Musculoskeletal System Disorder Market Size (2019-2030)
9.2 Latin America Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Musculoskeletal System Disorder Market Size by Country (2019-2024)
9.4 Latin America Musculoskeletal System Disorder Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Musculoskeletal System Disorder Market Size (2019-2030)
10.2 Middle East & Africa Musculoskeletal System Disorder Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2019-2024)
10.4 Middle East & Africa Musculoskeletal System Disorder Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AB Science
11.1.1 AB Science Company Detail
11.1.2 AB Science Business Overview
11.1.3 AB Science Musculoskeletal System Disorder Introduction
11.1.4 AB Science Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.1.5 AB Science Recent Development
11.2 AbGenomics International, Inc.
11.2.1 AbGenomics International, Inc. Company Detail
11.2.2 AbGenomics International, Inc. Business Overview
11.2.3 AbGenomics International, Inc. Musculoskeletal System Disorder Introduction
11.2.4 AbGenomics International, Inc. Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.2.5 AbGenomics International, Inc. Recent Development
11.3 Alder BioPharmaceuticals,Inc.
11.3.1 Alder BioPharmaceuticals,Inc. Company Detail
11.3.2 Alder BioPharmaceuticals,Inc. Business Overview
11.3.3 Alder BioPharmaceuticals,Inc. Musculoskeletal System Disorder Introduction
11.3.4 Alder BioPharmaceuticals,Inc. Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.3.5 Alder BioPharmaceuticals,Inc. Recent Development
11.4 Amgen Inc.
11.4.1 Amgen Inc. Company Detail
11.4.2 Amgen Inc. Business Overview
11.4.3 Amgen Inc. Musculoskeletal System Disorder Introduction
11.4.4 Amgen Inc. Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.4.5 Amgen Inc. Recent Development
11.5 Lexicon Pharmaceuticals, Inc.
11.5.1 Lexicon Pharmaceuticals, Inc. Company Detail
11.5.2 Lexicon Pharmaceuticals, Inc. Business Overview
11.5.3 Lexicon Pharmaceuticals, Inc. Musculoskeletal System Disorder Introduction
11.5.4 Lexicon Pharmaceuticals, Inc. Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.5.5 Lexicon Pharmaceuticals, Inc. Recent Development
11.6 LG Chem
11.6.1 LG Chem Company Detail
11.6.2 LG Chem Business Overview
11.6.3 LG Chem Musculoskeletal System Disorder Introduction
11.6.4 LG Chem Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.6.5 LG Chem Recent Development
11.7 OrthoTrophix, Inc.
11.7.1 OrthoTrophix, Inc. Company Detail
11.7.2 OrthoTrophix, Inc. Business Overview
11.7.3 OrthoTrophix, Inc. Musculoskeletal System Disorder Introduction
11.7.4 OrthoTrophix, Inc. Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.7.5 OrthoTrophix, Inc. Recent Development
11.8 Tarsa Therapeutics, Inc.
11.8.1 Tarsa Therapeutics, Inc. Company Detail
11.8.2 Tarsa Therapeutics, Inc. Business Overview
11.8.3 Tarsa Therapeutics, Inc. Musculoskeletal System Disorder Introduction
11.8.4 Tarsa Therapeutics, Inc. Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.8.5 Tarsa Therapeutics, Inc. Recent Development
11.9 PhytoHealth Corporation
11.9.1 PhytoHealth Corporation Company Detail
11.9.2 PhytoHealth Corporation Business Overview
11.9.3 PhytoHealth Corporation Musculoskeletal System Disorder Introduction
11.9.4 PhytoHealth Corporation Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.9.5 PhytoHealth Corporation Recent Development
11.10 Eisai Co., Ltd
11.10.1 Eisai Co., Ltd Company Detail
11.10.2 Eisai Co., Ltd Business Overview
11.10.3 Eisai Co., Ltd Musculoskeletal System Disorder Introduction
11.10.4 Eisai Co., Ltd Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.10.5 Eisai Co., Ltd Recent Development
11.11 Astellas Pharma Inc.
11.11.1 Astellas Pharma Inc. Company Detail
11.11.2 Astellas Pharma Inc. Business Overview
11.11.3 Astellas Pharma Inc. Musculoskeletal System Disorder Introduction
11.11.4 Astellas Pharma Inc. Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.11.5 Astellas Pharma Inc. Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Detail
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Musculoskeletal System Disorder Introduction
11.12.4 AstraZeneca Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.12.5 AstraZeneca Recent Development
11.13 Baxter
11.13.1 Baxter Company Detail
11.13.2 Baxter Business Overview
11.13.3 Baxter Musculoskeletal System Disorder Introduction
11.13.4 Baxter Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.13.5 Baxter Recent Development
11.14 GlaxoSmithKline PLC
11.14.1 GlaxoSmithKline PLC Company Detail
11.14.2 GlaxoSmithKline PLC Business Overview
11.14.3 GlaxoSmithKline PLC Musculoskeletal System Disorder Introduction
11.14.4 GlaxoSmithKline PLC Revenue in Musculoskeletal System Disorder Business (2019-2024)
11.14.5 GlaxoSmithKline PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
